Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by forhandlarenon Oct 04, 2022 2:26pm
136 Views
Post# 35004772

RE:Irrational meets rational

RE:Irrational meets rational 1) In theory I agree, but based on what's known about the two last deals we're in the dark and trust is low - hence the share price. Unknown timeline also speaks to it. The two first deals were pretty good, nailed by another CEO who's long gone.

2) I want Howard to confirm change of CEO, floating an idea via PRC Partners does not cut it, especially when they proved to be so wrong about the upfront.

The share price would double or triple if Howard announce his retirement! In fact, that could trigger sustainable and substantial higher share price.

3) Since the pet deal would include multiple partners there's a chance - in fact I demand it - that deal numbers could be communicated. But in general I don't see this 10x to materialize over night. They prioritize revenue streams down the road.

Surprise me, please!

4) In theory I agree, but what's the plan to finance the expansion? Dilution? French grants?

Communicate this to the market!
<< Previous
Bullboard Posts
Next >>